Paper35243249
NanoLuc reporters identify COL4A5 nonsense mutations susceptible to drug-induced stop codon readthrough.
Omachi K and 3 others. iScience, 2022. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. NanoLuc reporters identify COL4A5 nonsense mutations susceptible to drug-induced stop codon readthrough. Papers, record 35243249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35243249
- Cell line
- HEK293T2,726 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- NanoLuc reporters identify COL4A5 nonsense mutations susceptible to drug-induced stop codon readthrough.
- PubMed
Connected records4
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DK078314 | NIDDK NIH HHS | United States | R01DK078314 | PubMed and NIH | NIH RePORTER |
| R01 DK128660 | NIDDK NIH HHS | United States | R01DK128660 | PubMed and NIH | NIH RePORTER |
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28145797 | Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells. | RNA Biol | 2017 | https://conductscience.org/library/papers/28145797 | PubMed |
| 2 | 32198346 | 2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations. | Nat Commun | 2020 | https://conductscience.org/library/papers/32198346 | PubMed |
| 3 | 7987396 | Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. | Nat Genet | 1994 | https://conductscience.org/library/papers/7987396 | PubMed |
| 4 | 1985905 | Use of the polymerase chain reaction to clone and sequence a cDNA encoding the bovine alpha 3 chain of type IV collagen. | J Biol Chem | 1991 | https://conductscience.org/library/papers/1985905 | PubMed |
| 5 | 28691931 | Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28691931 | PubMed |
| 6 | 25733896 | Nonsense suppression by near-cognate tRNAs employs alternative base pairing at codon positions 1 and 3. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/25733896 | PubMed |
| 7 | 10686428 | Aminoglycoside antibiotics. | Audiol Neurootol | 2000 | https://conductscience.org/library/papers/10686428 | PubMed |
| 8 | 27407112 | Novel small molecules potentiate premature termination codon readthrough by aminoglycosides. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/27407112 | PubMed |
| 9 | 30359426 | The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential. | PLoS One | 2018 | https://conductscience.org/library/papers/30359426 | PubMed |
| 10 | 6250829 | 7-S collagen: characterization of an unusual basement membrane structure. | Eur J Biochem | 1980 | https://conductscience.org/library/papers/6250829 | PubMed |
| 11 | 30582011 | Establishment of X-linked Alport syndrome model mice with a Col4a5 R471X mutation. | Biochem Biophys Rep | 2019 | https://conductscience.org/library/papers/30582011 | PubMed |
| 12 | 12631109 | Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. | Kidney Int | 2003 | https://conductscience.org/library/papers/12631109 | PubMed |
| 13 | 31120902 | The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418. | PLoS One | 2019 | https://conductscience.org/library/papers/31120902 | PubMed |
| 14 | 11970952 | Crystal structure of NC1 domains. Structural basis for type IV collagen assembly in basement membranes. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11970952 | PubMed |
| 15 | 32299679 | A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome. | Kidney Int | 2020 | https://conductscience.org/library/papers/32299679 | PubMed |
| 16 | 22699498 | Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22699498 | PubMed |
| 17 | 15200416 | Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines. | Kidney Int | 2004 | https://conductscience.org/library/papers/15200416 | PubMed |
| 18 | 12815141 | Alport's syndrome, Goodpasture's syndrome, and type IV collagen. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12815141 | PubMed |
| 19 | 1882840 | Sequence and localization of a partial cDNA encoding the human alpha 3 chain of type IV collagen. | Am J Hum Genet | 1991 | https://conductscience.org/library/papers/1882840 | PubMed |
| 20 | 33558100 | Targeting G542X CFTR nonsense alleles with ELX-02 restores CFTR function in human-derived intestinal organoids. | J Cyst Fibros | 2021 | https://conductscience.org/library/papers/33558100 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42402511 | New therapeutic hope for rare podocytopathies. | Pediatr Nephrol | 2026 | https://conductscience.org/library/papers/42402511 | PubMed |
| 42367582 | Tetrahedral DNA nanostructure-delivered suppressor tRNA ameliorates nephropathy in COL4A5 nonsense mutation-mediated Alport syndrome mice. | NAR Mol Med | 2026 | https://conductscience.org/library/papers/42367582 | PubMed |
| 41417821 | Anticodon-edited tRNA enables translational readthrough of COL4A5 premature termination codons. | PLoS One | 2025 | https://conductscience.org/library/papers/41417821 | PubMed |
| 41411050 | Splice modulation of COL4A5 reinstates collagen IV assembly in an organoid model of Alport syndrome. | JCI Insight | 2026 | https://conductscience.org/library/papers/41411050 | PubMed |
| 41274954 | Translational readthrough therapy for ADPKD induces polycystin1 expression and partially rescues functional deficits in PKD1 mutant cells. | Sci Rep | 2025 | https://conductscience.org/library/papers/41274954 | PubMed |
| 40567900 | A comprehensive splicing characterization of COL4A5 mutations and prognostic significance in a single cohort with X-linked alport syndrome. | Front Genet | 2025 | https://conductscience.org/library/papers/40567900 | PubMed |
| 39548215 | Collagen formation, function and role in kidney disease. | Nat Rev Nephrol | 2025 | https://conductscience.org/library/papers/39548215 | PubMed |
| 39485497 | Mechanisms of podocyte injury in genetic kidney disease. | Pediatr Nephrol | 2025 | https://conductscience.org/library/papers/39485497 | PubMed |
| 39223427 | Mechanisms of assembly and remodelling of the extracellular matrix. | Nat Rev Mol Cell Biol | 2024 | https://conductscience.org/library/papers/39223427 | PubMed |
| 38812923 | Progress in therapeutic targets on podocyte for Alport syndrome. | J Transl Int Med | 2024 | https://conductscience.org/library/papers/38812923 | PubMed |
| 38579684 | Genetics of cystogenesis in base-edited human organoids reveal therapeutic strategies for polycystic kidney disease. | Cell Stem Cell | 2024 | https://conductscience.org/library/papers/38579684 | PubMed |
| 37657665 | En route towards a personalized medicine approach: Innovative therapeutic modalities for connective tissue disorders. | Matrix Biol | 2023 | https://conductscience.org/library/papers/37657665 | PubMed |
| 37511424 | Evaluation of Novel Enhancer Compounds in Gentamicin-Mediated Readthrough of Nonsense Mutations in Rett Syndrome. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37511424 | PubMed |
| 37047074 | Emerging Personalized Opportunities for Enhancing Translational Readthrough in Rare Genetic Diseases and Beyond. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047074 | PubMed |
| 36979640 | Recoding of Nonsense Mutation as a Pharmacological Strategy. | Biomedicines | 2023 | https://conductscience.org/library/papers/36979640 | PubMed |
| 36428516 | PTC124 Rescues Nonsense Mutation of Two Tumor Suppressor Genes NOTCH1 and FAT1 to Repress HNSCC Cell Proliferation. | Biomedicines | 2022 | https://conductscience.org/library/papers/36428516 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCDC6 | 8030 | PubTator's text mining | https://conductscience.org/library/genes/8030 | NCBI Gene |
| COL4A3 | 1285 | PubTator's text mining | https://conductscience.org/library/genes/1285 | NCBI Gene |
| COL4A4 | 1286 | PubTator's text mining | https://conductscience.org/library/genes/1286 | NCBI Gene |
| COL4A5 | 1287 | PubTator's text mining | https://conductscience.org/library/genes/1287 | NCBI Gene |
| IGKV2D-26 | 28884 | PubTator's text mining | https://conductscience.org/library/genes/28884 | NCBI Gene |
| LAMB2 | 3913 | PubTator's text mining | https://conductscience.org/library/genes/3913 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35243249
GET https://conductscience.org/api/papers/v1/35243249/references?page=2